Network and Learn: Research Park Lunch & Learn
Alameda, CA – September 13, 2024 – Emery Pharma, a leading contract research organization (CRO) specializing in preclinical drug development, is excited to announce an upcoming event where its founder and CEO, Dr. Ron Najafi, will share his entrepreneurial journey. The event will take place on September 26, 2024, at the Retreat in the Research Park, Alameda, California.
During this exclusive lunch and learn meeting, Dr. Najafi will provide an inside look into the founding and growth of Emery Pharma, which offers a wide range of services, including analytical, bioanalytical, microbiology, and cell biology, as well as drug and impurity characterization. Emery Pharma will be highlighting their expertise in supporting the medical device industry with extractable and leachable testing, as well as providing comprehensive CMC, cGMP/GLP support.
Attendees will gain valuable insights from Dr. Najafi’s personal experiences, including the challenges and successes he encountered in taking his previous company public and how those experiences shaped his vision for Emery Pharma. He will also discuss the strategic decisions that led to the successful establishment of Emery Pharma in 2011. Along with that he will share the pivotal moments that drove the company’s growth and recognition in Alameda’s Research Park.
“We are excited to welcome all Research Park tenants to join us for this insightful session,” said Dr. Najafi. “This is a great opportunity to share our story, exchange ideas, and foster collaboration within our Research Park colleagues.”
Event Details:
- Date: September 26, 2024
- Time: 12:00 PM – 1:30 PM
- Location: The Research Park, Marina Village (2020 Challenger Dr. Suite 101, Alameda, CA 94501)
All Research Park tenants and local clients are invited to attend. Lunch will be provided, and there will be an opportunity for Q&A and networking after the presentation.
About Emery Pharma:
Emery Pharma, based in Alameda, California, is a full-service contract research organization (CRO) supporting early-stage biopharmaceutical companies with a wide array of services in analytical chemistry, bioanalytical chemistry, microbiology, and cell biology. With a state-of-the-art facility, Emery Pharma offers cutting-edge solutions to support drug development, CMC, and regulatory compliance.
